Juggling #RadOnc and #healthcare resources Northwell Health during #COVID19 pandemic, in #AdvancesRO preprint: astro.org/ASTRO/media/AS…
💡At Memorial Sloan Kettering Radiation Oncology we hired a radiation anatomist to ⬇️ #radonc burden of contouring OARs (esp complex ones w/o autoseg).
We evaluated this prospectively ⚖️ and found ⬆️ quality and ⬇️ time to contour approval.
📰out now in #AdvancesRO : advancesradonc.org/article/S2452-…
New in #AdvancesRO : In a large single-institution series of heavily pretreated pts with #colorectalcancer liver metastases tx with #radiation , low BED10 & multiple prior lines of therapy were associated with lower local control & overall survival. #crcsm
clinicalkey.com/#!/content/pla…
We are honored to announce that Rachel Jimenez, MD will become editor-in-chief of Advances in Radiation Oncology in March, succeeding founding editor Dr. Robert Miller. Read more here: ow.ly/FQm850Qg0XO
Mass General Cancer Center @HarvardMed MGH Breast Oncology #RadOnc #AdvancesRO
Congrats to Eric M Chung & DrKamrava on their paper in #AdvancesRO
Limited locoregional failures after neoadj chemo + SBRT in BR/LA pancreatic cancer
Most LRF fall within 'triangle' between PV, SMA, CA, suggesting coverage of triangle may improve LC
advancesradonc.org/article/S2452-…
Thank you #AdvancesRO . Isabel Jackson Dr. Curtiland Deville C. Jillian Tsai, MD, PhD Dr. Sharad Goyal Dr. Kathleen Hintenlang Bradford Hoppe Dr. Gregory Videtic Dr. William Small and of course @RadOncOA !
advancesradonc.org/article/S2452-…
In a retrospective study across Memorial Sloan Kettering Radiation Oncology network, we evaluated use of RT for elderly ER+ early-stage #bcsm before/after implementing a productivity-based bonus metric and found *no change*.
More on incentive design + central QA in #AdvancesRO 📰: advancesradonc.org/article/S2452-…
This #AdvancesRO Dillon Li Annemarie Fernandes Shepherd analysis shows a 27% risk of G2+ radiation-induced lung toxicities after multiple courses of lung #SBRT . Female sex, synchronous SBRT, prior G2+ RILT, & higher composite lung V20 may be risk factors for G2+ RILT.
☢️clinicalkey.com/#!/content/pla…
Xerostomia is a common side effect of RT for patients w/ #HeadAndNeckCancer . Dr. Todd McNutt & his team showed how spatial dose distribution in salivary glands influenced injury & recovery. More on the #AdvancesRO article & his ROI-funded research bit.ly/McNuttROI #radonc
John Pluvinage kicking off medical student journal club talks as part of Stanford University's virtual #radonc clerkship. Impressive talks by all this AM and great QA discussions with faculty&residents. Looking fwd to Day 2 of talks tomorrow! ASTRO #AdvancesRO
Credit where due, Advances in RadOnc temporarily removed the paper, I expect for a less misleading re-write and more clear COI reporting.
It was arguing for daily IGRT so that contact could be more lucrative for companies trying to build on the back of the technique.
And check out this year’s #AdvancesRO selected articles to see how #WomenWhoCurie leverage #SoMe ! ASTRO ARRO
New in #AdvancesRO by rising PGY4 Dr Alexandra Dreyfuss: Tumor bed boost in BCT was not associated with LRR or RFS. As boosts were used more frequently in those with high-risk features, it is possible that it may have mitigated risk of recurrence. #bcsm
sciencedirect.com/science/articl…
Recommendations for the optimal management of #prostatecancer in #COVID19Pandemic time. ASTRO Nicholas Zaorsky, MD MS #AdvancesRO #pcsm #RadOnc
